Indegene (NSE:INDGN) Beginning Cash Position : ₹0 Mil (As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Indegene Beginning Cash Position?

Indegene's Beginning Cash Position for the quarter that ended in Mar. 2025 was ₹0 Mil.

Indegene's annual Beginning Cash Position declined from Mar. 2023 (₹5,063 Mil) to Mar. 2024 (₹736 Mil) but then increased from Mar. 2024 (₹736 Mil) to Mar. 2025 (₹1,886 Mil).

Indegene Beginning Cash Position Historical Data

The historical data trend for Indegene's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indegene Beginning Cash Position Chart

Indegene Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Mar25

Beginning Cash Position

1,195.10

1,333.62

5,063.00

736.00

1,886.00

Indegene Quarterly Data
	Mar21	Mar22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Beginning Cash Position	Get a 7-Day Free Trial						-	-	-	-	-

Indegene Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Indegene Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Indegene's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Indegene Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Indegene Ltd (NSE:INDGN) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

544172:India

Address

Outer Ring Road, Aspen Block G4, 3rd Floor, Manyata Embassy Business Park, Nagawara, Bengaluru, KA, IND, 560045

Website

https://www.indegene.com

Indegene Ltd provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its portfolio of solutions covers all aspects of commercial, medical, regulatory, and R&D operations of life sciences companies. The company segment includes Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation, and Others. Key revenue is generated from the Omnichannel Activation segment.

Indegene Headlines

No Headlines